Traditional drug development is often quoted as requiring over $1billion and more than 10 years to bring a new drug to market. Scientists at twoXAR use their proprietary computational drug discovery platform to discover, screen, and prioritize novel drug candidates with potential applications in many disease areas.

Pharma has been lagging behind many other industries in incorporating AI into their processes. More recently however, AI techniques are beginning to be applied across the entire drug discovery and development process, from designing new molecules and performing predictive analytics to supporting clinical trials. Andrew will navigate from the conceptual to the practical applications of AI, illustrating where AI is being used in healthcare, and describing how to leverage the capabilities of AI for significant improvements in drug discovery and development.